Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2019
At a glance
- Drugs Human papillomavirus vaccine recombinant nonavalent Merck (Primary)
- Indications Anal cancer; Cervical cancer; Condylomata acuminata; Human papillomavirus infections; Vulvovaginal cancer
- Focus Pharmacodynamics
- 29 Jan 2019 Planned End Date changed from 1 Feb 2020 to 1 Nov 2020.
- 29 Jan 2019 Planned primary completion date changed from 1 Feb 2020 to 1 Nov 2020.
- 31 May 2018 Planned primary completion date changed from 1 Jan 2020 to 1 Feb 2020.